This peptide competes with MEK1 as a tumor suppressor to reduce MAPK1 phosphorylation, which in turn inhibits the activation of MAPK1 and its downstream factors, thereby inhibiting the proliferation and metastasis of GC cells (13). This evidence concerns the gene MAP2K1 and gastric cancer.